Drug Trial Radar · NCT07746687
A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
440
Planned (sponsor's estimate)
Start
Oct 5, 2026
Primary completion
Sep 11, 2029
Study completion Jul 1, 2030
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Aug 5, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess how well JNJ-95597528 works when compared to placebo in adult participants with moderate to severe asthma (long-term condition that affects the airways in your lungs).
Conditions
- Asthma
Interventions
JNJ-95597528Drug
JNJ-95597528 will be administered as subcutaneous (SC) injection.
PlaceboDrug
Placebo will be administered as SC injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Asthma Exacerbations Through Week 48Time frame: Up to Week 48
Locations
19 sites in 5 countries. Site status is shown where the registry gives one.
Allianz Research Institute, Inc.
Westminster, California · Recruiting
Boston Specialists
Boston, Massachusetts · Recruiting
Clinical Research Institute
Minneapolis, Minnesota · Recruiting
Midwest Clinical Research LLC
St Louis, Missouri · Recruiting
Equity Medical
The Bronx, New York · Recruiting
OK Clinical Research
Edmond, Oklahoma · Recruiting
Allergy Asthma and Clinical Research Center Martha Tarpay MD
Oklahoma, Texas · Recruiting
INAER - Investigacion en Alergias y Enfermedades Respiratorias
Buenos Aires, Argentina · Recruiting
Instituto de Medicina Respiratoria IMER
Córdoba, Argentina · Recruiting
Fundacion Scherbovsky
Mendoza, Argentina · Recruiting
Instituto De Especialidades De La Salud SRL
Rosario, Argentina · Recruiting
IBAMEDICA Propiedad de IBA Santa Fe S.A.S
Santa Fe, Argentina · Recruiting
China Japan Friendship Hospital
Beijing, China · Recruiting
Changzhou No 2 Peoples Hospital
Changzhou, China · Recruiting
Ningbo medical center lihuili hospital
Ningbo, China · Recruiting
Shanxi Bethune Hospital
Taiyuan, China · Recruiting
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel · Recruiting
Idaimae Minami4jo Internal Medicine
Sapporo, Japan · Recruiting
Tokyo Shinagawa Hospital
Shinagawa City, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.